Thomas J Herzog

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Topics

Natural Killer Cells

Top Venues

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Future oncology (London, England)

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Foods (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

John A Bouranis, Carmen P Wong, Laura M Beaver, Sandra L Uesugi, Ethan M Papenhausen, Jaewoo Choi, Edward W Davis, Adilson Nunes Da Silva, Newton Kalengamaliro, Rekha Chaudhary, Jordan Kharofa, Vinita Takiar, Thomas J Herzog, William Barrett, Emily Ho
Sulforaphane Bioavailability in Healthy Subjects Fed a Single Serving of Fresh Broccoli Microgreens. Foods (Basel, Switzerland) 12 (20) (2023)
Rebecca C Arend, Bradley J Monk, Ronnie Shapira-Frommer, Ashley F Haggerty, Edwin A Alvarez, Amnon Amit, Angeles A Secord, Carolyn Muller, Antonio Casado Herraez, Thomas J Herzog, Krishnansu S Tewari, Joshua G Cohen, Marilyn Huang, Adelya Yachnin, Laura L Holeman, Jonathan A Ledermann, Tamar Rachmilewitz Minei, Marc E Buyse, Shifra Fain Shmueli, Michal Lavi, Dror Harats, Richard T Penson, null null
Ofranergene Obadenovec (Ofra-Vec, VB-111) With Weekly Paclitaxel for Platinum-Resistant Ovarian Cancer: Randomized Controlled Phase III Trial (OVAL Study/GOG 3018). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Thomas J Herzog, Shaun A Wahab, Mansoor Raza Mirza, Bhavana Pothuri, Ignace Vergote, Whitney S Graybill, Izabela A Malinowska, Whitney York, Jean A Hurteau, Divya Gupta, Antonio Gonzáles Martin, Bradley J Monk
Optimizing disease progression assessment using blinded central independent review and comparing it with investigator assessment in the PRIMA/ENGOT-ov26/GOG-3012 trial: challenges and solutions. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 33 (11) (2023)
Thomas J Herzog, John L Hays, Joyce N Barlin, Joseph Buscema, Noelle G Cloven, Lynn R Kong, Nidhi Kumar Tyagi, Grainger S Lanneau, Beverly J Long, Robert L Marsh, Shelly M Seward, David C Starks, Stephen Welch, Kathleen M Moore, Panagiotis A Konstantinopoulos, Lucy Gilbert, Bradley J Monk, David M O'Malley, Xiwei Chen, Rita Dalal, Robert L Coleman, Jalid Sehouli
ARTISTRY-7: Phase III trial of nemvaleukin alfa plus pembrolizumab vs chemotherapy for platinum-resistant ovarian cancer. Future oncology (London, England) (2023)